Share on StockTwits

Shares of Flamel Technologies S.A. (NASDAQ:FLML) have received an average rating of “Buy” from the eight analysts that are currently covering the company, Analyst Ratings News reports. Eight analysts have rated the stock with a buy rating, The average 12-month target price among brokerages that have covered the stock in the last year is $17.90.

A number of analysts have recently weighed in on FLML shares. Analysts at Leerink Swann initiated coverage on shares of Flamel Technologies S.A. in a research note on Friday. They set an “outperform” rating and a $22.00 price target on the stock. Analysts at Zacks upgraded shares of Flamel Technologies S.A. from a “neutral” rating to an “outperform” rating in a research note on Tuesday, July 15th. They now have a $16.20 price target on the stock.

Shares of Flamel Technologies S.A. (NASDAQ:FLML) opened at 14.82 on Friday. Flamel Technologies S.A. has a one year low of $5.30 and a one year high of $15.75. The stock has a 50-day moving average of $14.11 and a 200-day moving average of $11.99. The company’s market cap is $567.1 million.

Flamel Technologies S.A. (NASDAQ:FLML) last announced its earnings results on Tuesday, July 29th. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.08) by $0.05. The company had revenue of $8.10 million for the quarter, compared to the consensus estimate of $9.92 million. During the same quarter in the prior year, the company posted ($1.29) earnings per share. On average, analysts predict that Flamel Technologies S.A. will post $-0.21 earnings per share for the current fiscal year.

Flamel Technologies SA has a pipeline of niche specialty pharmaceutical products. The Company’s drug delivery platforms are focused on developing safer, more efficacious formulations of drugs to address unmet medical needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.